Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
70.62 CAD | -3.38% | -2.03% | +21.42% |
04-15 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
04-12 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.12% | 297B | |
+8.23% | 147B | |
+56.15% | 128B | |
+20.17% | 81.38B | |
+9.24% | 76B | |
+19.76% | 62.92B | |
+10.77% | 58.63B | |
+9.25% | 48.36B | |
+29.69% | 35.87B |
- Stock Market
- Equities
- OVV Stock
- OVV Stock
- News Ovintiv Inc.
- Ovintiv : Morgan Stanley Adjusts Price Target on Ovintiv to $42 From $35, Maintains Overweight Rating